# Kiniksa Pharmaceuticals International, plc (KNSA)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KNSA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 457.87M | $ 48.02M | $ 96.83M | $ 8.90M | $ 654.15M |
| 2025 | $ 693.77M | $ 60.42M | $ 139.68M | $ 9.50M | $ 567.61M |
| 2024 | $ 444.86M | $ -45.40M | $ 26.71M | $ 9.86M | $ 438.44M |
| 2023 | $ 292.22M | $ 15.23M | $ 14.24M | $ 12.26M | $ 438.84M |
| 2022 | $ 245.96M | $ 204.84M | $ 6.37M | $ 5.92M | $ 396.15M |
| 2021 | $ 45.82M | $ -187.72M | $ -174.39M | $ 6.05M | $ 185.04M |
| 2020 | $ 0 | $ -205.59M | $ -174.29M | $ 6.99M | $ 311.94M |
| 2019 | $ 0 | $ -208.93M | $ -208.55M | $ 2.65M | $ 225.42M |
| 2018 | $ 0 | $ -136.33M | $ -113.98M | $ 0 | $ 279.27M |
| 2017 | $ 0 | $ -87.39M | $ -67.74M | $ 0 | $ -89.71M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.37 |
| Current Ratio | 3.90 |

## Other views

- [Metrics](https://sponda.capital/en/KNSA.md)
- [Charts](https://sponda.capital/en/KNSA/charts.md)
- [Compare](https://sponda.capital/en/KNSA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.